@StephptaylorCLT Thanks @StephptaylorCLT ! This award has such a rich history @UMIntMed. I'm honored and grateful for all my mentors, collaborators, and supporters.
It’s time for 12 Days of U-M Hospital Medicine Research!
I’ll highlight 12 holly jolly papers published and grants received by @UMIntMed HM faculty this year.
It’s been such a gift for me to get to work with this team!! 🎄🥼🧬🎄
#HailToTheHypothesis
The @US_FDA recently approved the first available therapeutic treatment for a rare, life-threatening genetic disorder, developed in the @UMich lab of researcher David Ginsburg. https://t.co/mYM1V0qKNI
TAK-755, developed in the HHMI laboratory of Professor David Ginsburg at the University of Michigan and licensed to Takeda, was approved by the FDA as the first treatment for patients with congenital thrombotic thrombocytopenic purpura (TTP).
NIH funding by institution for FY 2023
1 Johns Hopkins U $518M
2 UCSF $451M
3 U Michigan $436M
4 Penn $434M
5 UCLA $424M
6 Stanford $407M
7 Mass General $406M
8 Wash U. $404M
9 Yale $390M
10 Pitt $382M
11 Columbia $362M
12 Duke $360M
Congrats to @UMPhysiology PhD student @TangToBaVi for his first author paper in @eLife with the Ginsburg lab in @UMLifeSciences, showing hepatic incactivation of the cargo receptor SURF4 reduces PCSK9 and lipoprotein secretion reducing plasma cholesterol. https://t.co/QpX2YBQsIh
A warm welcome to @StephptaylorCLT as the new Chief of Hospital Medicine @UMIntMed! Some big shoes to fill from @vineet_chopra but I'm very excited for this next chapter for our division.
We are excited to announce that Dr. @StephptaylorCLT will become the next Chief of the Division of Hospital Medicine! Dr. Taylor, who succeeds Dr. @vineet_chopra & Dr. Scott Flanders, will take the reins from Interim Division Chief, Dr. Robert Chang, effective 4/1/23.
Many thanks to all involved, especially @emilyjsher for leading the project and the @cwobus lab @UMMicroImmuno for the fantastic collaboration! (15/15)
Overall, our findings identify host factors involved in SARS-CoV-2 infection and demonstrate a very high degree of cell type specificity for ACE2 regulatory networks. (14/15)